Aurobindo Pharma Limited (AUROPHARMA) — Long-term Investment Intensity
Aurobindo Pharma Limited (AUROPHARMA) has a Long-term Investment Intensity of 1.7% as of September 2019. Long-term investments of Rs4.68 Billion represent 1.7% of total assets of Rs272.89 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See AUROPHARMA net asset value for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Aurobindo Pharma Limited Long-term Investment Intensity (2014–2019)
This chart shows how Aurobindo Pharma Limited's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2019. As of September 2019, the intensity stands at 1.7%, reflecting long-term investments of Rs4.68 Billion against total assets of Rs272.89 Billion INR. Also explore AUROPHARMA asset base for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Aurobindo Pharma Limited (2014–2019)
The table below presents the year-by-year Long-term Investment Intensity for Aurobindo Pharma Limited from 2014 to 2019, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see AUROPHARMA stock market capitalisation.
| Year | LT Investment Intensity | LT Investments (INR) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2019 | 1.4% | Rs3.60 Billion | Rs264.54 Billion | ▼ -0.1 pp |
| 2018 | 1.5% | Rs3.12 Billion | Rs211.01 Billion | ▼ 0.0 pp |
| 2017 | 1.5% | Rs2.46 Billion | Rs162.49 Billion | ▲ +0.7 pp |
| 2016 | 0.8% | Rs1.23 Billion | Rs159.20 Billion | ▲ +0.8 pp |
| 2015 | 0.0% | Rs1.33 Million | Rs129.14 Billion | ▼ -0.2 pp |
| 2014 | 0.2% | Rs197.53 Million | Rs94.90 Billion | — |